The district court erred by admitting untimely expert testimony on noninfringement and by refusing to grant a new trial after the jury found noninfringement. Trudell Medical International (“Trudell”) sued D R Burton...more
2/14/2025
/ Appeals ,
Claim Construction ,
Daubert Standards ,
Discovery ,
Evidence ,
Expert Testimony ,
Federal Rules of Civil Procedure ,
Intellectual Property Litigation ,
Patent Infringement ,
Patent Litigation ,
Remand ,
Rule of Evidence 702
CAREDX, INC. V. NATERA, INC.
Before Lourie, Bryson, and Hughes -
Summary: Expert testimony that steps of challenged patent claims were unconventional failed to preclude summary judgment of ineligibility where...more
7/19/2022
/ Abstract Ideas ,
Alice/Mayo ,
Claim Construction ,
Evidence ,
Expert Testimony ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Section 101 ,
Summary Judgment
Traxcell Techs., LLC v. Sprint Commn’s Co. et al Before Prost, O’Malley, and Stoll.
Appeal from the Eastern District of Texas.
Summary: A patentee’s extensive citations to evidence failed to avoid summary judgment of...more
10/14/2021
/ Claim Construction ,
Evidence ,
Indefiniteness ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Sprint ,
Summary Judgment ,
Telecommunications ,
Verizon
HVLPO2, LLC v. OXYGEN FROG, LLC -
Before Newman, Moore, and Chen. Appeal from the United States District Court for the Northern District of Florida.
Summary: It is an abuse of discretion to permit a witness to testify...more
2/10/2020
/ Abuse of Discretion ,
Admissibility ,
Appeals ,
Discovery ,
Evidence ,
Expert Testimony ,
Expert Witness ,
Judgment As A Matter Of Law ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patents ,
Remand ,
Reversal ,
Rule of Evidence 702
PERSION PHARMACEUTICALS LLC v. ALVOGEN MALTA OPERATIONS LTD.
Before O’Malley, Reyna, and Chen. Appeal from the U.S. District Court for the District of Delaware.
Summary: The FDA’s acceptance of safety data for a...more
12/30/2019
/ Appeals ,
Evidence ,
FDA Approval ,
Motivation to Combine ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Reaffirmation